Equities research analysts expect Imperva Inc (NASDAQ:IMPV) to announce sales of $84.18 million for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Imperva’s earnings, with estimates ranging from $83.50 million to $86.51 million. Imperva reported sales of $72.31 million during the same quarter last year, which indicates a positive year over year growth rate of 16.4%. The firm is expected to report its next quarterly earnings results on Thursday, May 3rd.
According to Zacks, analysts expect that Imperva will report full-year sales of $84.18 million for the current financial year, with estimates ranging from $370.60 million to $375.45 million. For the next year, analysts expect that the business will post sales of $426.81 million per share, with estimates ranging from $422.00 million to $434.00 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow Imperva.
Imperva (NASDAQ:IMPV) last announced its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.27 by $0.13. The company had revenue of $91.10 million for the quarter, compared to the consensus estimate of $91.11 million. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. Imperva’s quarterly revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.32 EPS.
Shares of Imperva (IMPV) traded down $1.05 during trading on Friday, reaching $46.65. The company’s stock had a trading volume of 383,227 shares, compared to its average volume of 401,292. The company has a market cap of $1,590.00, a P/E ratio of 69.63 and a beta of 1.79. Imperva has a 12 month low of $37.17 and a 12 month high of $52.40.
In related news, CRO Michael D. Mooney sold 24,454 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the completion of the sale, the executive now directly owns 24,454 shares in the company, valued at approximately $1,153,739.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Anthony J. Bettencourt sold 66,037 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $46.98, for a total value of $3,102,418.26. Following the sale, the director now owns 66,037 shares of the company’s stock, valued at $3,102,418.26. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently modified their holdings of IMPV. SG Americas Securities LLC purchased a new stake in shares of Imperva during the 3rd quarter worth $134,000. First Quadrant L P CA purchased a new stake in shares of Imperva during the 3rd quarter worth $136,000. Ameritas Investment Partners Inc. lifted its stake in shares of Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after purchasing an additional 464 shares during the last quarter. Quadrature Capital Ltd purchased a new stake in shares of Imperva during the 4th quarter worth $224,000. Finally, Koch Industries Inc. purchased a new stake in shares of Imperva during the 4th quarter worth $229,000. Hedge funds and other institutional investors own 95.91% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Zacks: Brokerages Expect Imperva Inc (IMPV) Will Announce Quarterly Sales of $84.18 Million” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3229204/zacks-brokerages-expect-imperva-inc-impv-will-announce-quarterly-sales-of-84-18-million.html.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.